Showing 2101-2110 of 3315 results for "".
- Gyroscope Therapeutics Strengthens Senior Leadership Ahead of Next Stage of Company Growthhttps://modernod.com/news/gyroscope-therapeutics-strengthens-senior-leadership-ahead-of-next-stage-of-company-growth/2477297/Gyroscope Therapeutics announced the strengthening of its leadership team with the hiring of Nadia Waheed, MD, MPH, from Tufts University School of Medicine in Boston as Chief Medical Officer (CMO), and the promotion of Jane Hughes, PhD, formerly VP Translational Research, to Chief Scientific Off
- FDA Approves CooperVision Biofinity Toric Multifocal Contact Lenseshttps://modernod.com/news/fda-approves-coopervision-biofinity-toric-multifocal-contact-lenses/2477277/The FDA has granted CooperVision approval for its new Biofinity toric multifocal contact lenses. The product combines the optical designs of CooperVision’s Biofinity toric—the most prescribed toric lens on the market1—and Biofinity multifocal to provide patients with astigmatism and pr
- Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseaseshttps://modernod.com/news/trefoil-therapeutics-selects-agc-biologics-as-lead-manufacturer-of-tthx1114-for-treatment-of-corneal-diseases/2477274/AGC Biologics, a global Contract Development and Manufacturing Organization for Biopharmaceuticals, and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound, TTHX1114. Trefoil is developing products based on this engineered form of FGF-1 to restore
- Staar Surgical Announces the EVO Implantable Lens US Clinical Trial is Underwayhttps://modernod.com/news/staar-surgical-announces-the-evo-implantable-lens-us-clinical-trial-is-underway/2477273/Staar Surgical announced the first patient was implanted in the company’s US human clinical study for its EVO ICL family of lenses. The investigational study, “A Multicenter Clinical Evaluation of the EVO/EVO+ Visian Implantable Collamer Lens,” will be conducted at more than a dozen ophthalmology
- Mojo Vision Developing Smart Contact Lenshttps://modernod.com/news/mojo-vision-developing-smart-contact-lens/2477237/Mojo Vision announced it is building what it calls the “world’s first true smart contact lens,” called the Mojo Lens. Mojo Lens is a contact lens with a built-in display that gives people useful and timely information without forcing them to look down at a screen or losing focus on th
- Staar Surgical Gains Supplemental Lens Approval for EVO Visian ICL to Target Post-Cataract Market Opportunityhttps://modernod.com/news/staar-surgical-gains-supplemental-lens-approval-for-evo-visian-icl-to-target-post-cataract-market-opportunity/2477226/Staar Surgical announced it has gained CE Mark approval for use of its ICL as a supplemental or “piggyback” lens in post-cataract IOL surgery patients (pseudophakics). A supplemental EVO ICL is placed in front of the cataract IOL lens in post-cataract patients, just like the EVO ICL is placed in
- AbbVie Announces Leadership Team and Creation of New Business, Allergan Aesthetics, Upon Completion of Acquisitionhttps://modernod.com/news/abbvie-announces-leadership-team-and-creation-of-new-business-allergan-aesthetics-upon-completion-of-acquisition/2477216/AbbVie announced the creation of a new global business, Allergan Aesthetics, and the proposed leadership team for the combined company, effective upon the expected first-quarter 2020 close of the Allergan acquisition. Allergan Aesthetics will operate as a new global dedicated business wit
- Bausch + Lomb Launches Expanded Parameters for Biotrue ONEday for Astigmatism Daily Disposable Contact Lenseshttps://modernod.com/news/bausch-lomb-launches-expanded-parameters-for-biotrue-oneday-for-astigmatism-daily-disposable-contact-lenses/2477205/Bausch + Lomb announced the US launch of expanded parameters for Biotrue ONEday for Astigmatism daily disposable contact lenses. The expansion will increase the toric parameter range by more than 60%, offering eye care professionals and their astigmatic patients the largest parameter offering of
- Joel Leftwich Named Executive Director of William L. Hudson BVI Workforce Innovation Centerhttps://modernod.com/news/joel-leftwich-named-executive-director-of-william-l-hudson-bvi-workforce-innovation-orkforce-innovation-center/2477155/Envision announced today that Joel Leftwich has been named executive director of the William L. Hudson BVI Workforce Innovation Center. The mission of the center, which is based out of Envision’s Wichita, Kansas headquarters, is to train and employ individuals with visual impairments, place them
- Leiters and Prodigy Health Enter into National Sales and Marketing Agreementhttps://modernod.com/news/leiters-and-prodigy-health-enter-into-national-sales-and-marketing-agreement/2477157/Leiters and Prodigy Health have entered into a national sales and marketing agreement that will permit Prodigy Health to bring its ProdigyVision technology platform to the Leiters portfolio of 503B compounded sterile preparations in collaboration with the Leiters sal